Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1 ...
Dr. Reddy’s Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...
Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the ...
Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 ...
Am J Health Syst Pharm. 2005;62(23):2410-2412. To increase the flexibility in preparation time and storage and decrease waste after reconstituting pantoprazole sodium for injection, it would be ...
Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.
The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...
The analysis, based on data from sources including the USP Medicine Supply Map, found that 71% of the drugs identified as the most vulnerable are injectables, including sodium chloride injection, ...
Nausea, vomiting, diarrhea, mouth sores, drowsiness, muscle aches, and pain/redness/swelling at the injection site may occur. If any of these effects last or get worse, tell your doctor or ...
Dr. Reddy's Laboratories Ltd. is recalling select Levetiracetam in Sodium Chloride Injection in the United States citing mislabeling of infusion bag, according to the U.S.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果